Galmed Pharmaceuticals Announces the Filing of a Provisional Patent Application for the Use of Aramchol for the Treatment of Lipodystrophy
09 juin 2014 08h00 HE
|
LifeSci Advisors, LLC
TEL AVIV, Israel, June 9, 2014 (GLOBE NEWSWIRE) -- Galmed Pharmaceuticals Ltd. (Nasdaq:GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of...
Recently Published Independent Research Supports the Importance of Reverse Cholesterol Transport on NASH Pathogenesis
04 juin 2014 08h00 HE
|
LifeSci Advisors, LLC
TEL AVIV, Israel, June 4, 2014 (GLOBE NEWSWIRE) -- Galmed Pharmaceuticals Ltd. (Nasdaq:GLMD) ("Galmed"), a clinical-stage biopharmaceutical company focused on the development and commercialization of...